Skip to main content
. 2017 Aug 8;9(2):366–374. doi: 10.1111/jdi.12707

Table 1.

Demographic characteristics of 52 diabetes patients at various stages of chronic kidney disease

CKD 1 (n = 18) CKD 2 (n = 15) CKD 3 (n = 12) CKD 4 (n = 3) CKD 5 (n = 4) P‐value
Male, n (%) 5 (27.78) 11 (73.33) 8 (66.67) 2 (66.67) 0 (0) 0.014*
Age (years) 46.3 ± 10.7 56.5 ± 11.8 66.0 ± 15.9 71.0 ± 10.1 61.5 ± 3.7 0.001*
BMI (kg/m2) 28.3 ± 5.3 28.0 ± 7.5 27.1 ± 5.2 28.1 ± 2.3 27.8 ± 3.0 0.825
Duration of DM (years) 7.6 ± 4.3 9.0 ± 7.3 16.5 ± 12.9 15.0 ± 4.6 14.3 ± 4.2 0.036*
Hypertension, n (%) 11 (61.11) 9 (60.00) 11 (91.67) 3 (100.00) 4 (100.00) 0.121
SBP (mmHg) 129.6 ± 16.4 134.6 ± 9.7 128.1 ± 17.5 137.0 ± 20.1 125.3 ± 12.5 0.639
DBP (mmHg) 74.6 ± 9.7 77.9 ± 8.6 66.9 ± 15.6 70.7 ± 11.0 63.5 ± 5.2 0.021*
Cr (mg/dL) 0.62 ± 0.11 1.00 ± 0.16 1.50 ± 0.19 2.42 ± 0.73 4.31 ± 0.80 0.000*
eGFR (mL/min/1.73 m2) 115 ± 19 73 ± 8 44 ± 8 25 ± 5 11 ± 2 0.000*
HbA1c (%) 7.9 ± 1.8 8.0 ± 1.8 7.8 ± 1.5 6.5 ± 0.4 6.6 ± 0.5 0.249
UACR (mg/g) 185.5 ± 588.3 735.1 ± 2282.4 794.8 ± 1380.2 1,340.3 ± 1972.7 2,600.4 ± 843.8 0.004*
Hb 13.9 ± 1.7 13.8 ± 1.6 11.7 ± 1.9 12.2 ± 0.4 9.8 ± 1.4 0.002*
Antihypertensive agents
ACEI/ARB, n (%) 8 (72.73) 8 (88.89) 8 (72.73) 3 (100.00) 4 (100.00) 0.138
Beta‐blocker, n (%) 2 (18.18) 3 (33.33) 6 (54.55) 3 (100.00) 3 (75.00) 0.003*
CCB, n (%) 5 (45.45) 3 (33.33) 3 (27.27) 2 (66.67) 4 (100.00) 0.022*
Diuretics, n (%) 1 (9.09) 5 (55.56) 5 (45.45) 0 (0.00) 2 (50.00) 0.081

Values are presented as mean ± standard deviation or n (%). The anova was used for continuous variables; the χ2‐test was used for categorical variables. *P < 0.05.

ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; CCB, calcium channel blocker CKD, chronic kidney disease; Cr, creatinine; DBP, diastolic blood pressure; DM, diabetes mellitus; SBP, systolic blood pressure; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; HbA1c, glycated hemoglobin; UACR, urine albumin‐to‐creatinine ratio.